Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 10, 2023

BUY
$160.94 - $186.23 $804 - $931
5 Added 15.63%
37 $6,000
Q1 2023

May 10, 2023

BUY
$145.48 - $175.02 $1,018 - $1,225
7 Added 28.0%
32 $5,000
Q4 2022

Feb 01, 2023

SELL
$131.14 - $157.47 $393 - $472
-3 Reduced 10.71%
25 $3,000
Q3 2022

Nov 03, 2022

SELL
$148.29 - $182.55 $1,927 - $2,373
-13 Reduced 31.71%
28 $4,000
Q2 2022

Aug 09, 2022

BUY
$155.97 - $200.09 $935 - $1,200
6 Added 17.14%
41 $7,000
Q1 2022

Apr 22, 2022

BUY
$181.39 - $234.03 $6,348 - $8,191
35 New
35 $7,000
Q1 2020

May 19, 2020

SELL
$92.66 - $144.94 $1,575 - $2,463
-17 Closed
0 $0
Q4 2019

May 19, 2020

BUY
$116.25 - $133.25 $1,976 - $2,265
17 New
17 $2,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Disciplined Investments, LLC Portfolio

Follow Disciplined Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Disciplined Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Disciplined Investments, LLC with notifications on news.